Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Giant Cell Tumor of Bone × Indocyanine Green × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Lung Neoplasms 5 Breast Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Lymphatic Metastasis 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Breast Cancer Lymphedema 2 Brain Neoplasms 2 Vulvar Neoplasms 1 Uterine Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Soft Tissue Neoplasms 1 Sarcoma, Ewing 1 Right Hemicolectomy 1 Rhabdomyosarcoma 1 Parathyroid Diseases 1 Osteosarcoma 1 Neuroblastoma 1 Mixed Tumor, Mesodermal 1 Mesothelioma, Malignant 1 Melanoma 1 Margins of Excision 1 Lymphoma 1 Inflammatory Breast Neoplasms 1 Giant Cell Tumor of Tendon Sheath 1

Interventions

fludarabine 1 aldesleukin 1 Zoledronic Acid 1 Transurethral Resection of Bladder 1 Surgical Procedures, Operative 1 Nivolumab 1 Methods 1 Ipilimumab 1 Indocyanine Green 1 Denosumab 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Amputation, Surgical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07315828 2026-01-05

ICG-GCTB

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Phase 4 Recruiting

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon ⚡